Sign up to save your podcasts
Or
Share How Integrated Drug Development and Manufacturing Creates Speed Advantage in Contract Pharma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Integrated Drug Development and Manufacturing Creates Speed Advantage in Contract Pharma
“Process chemistry alone is no longer the whole story—it needs to be connected with engineering solutions, digital tools, and data utilization.”
Stefan Randl, Chief Scientific Officer at Siegfried, joined the Swiss-based CDMO in January 2025 after 16 years at Evonik, where he led innovation management for healthcare, ran drug substance operations in the US, and headed sales across Asia.
Read more.
View all episodes
By Life Science Networks“Process chemistry alone is no longer the whole story—it needs to be connected with engineering solutions, digital tools, and data utilization.”
Stefan Randl, Chief Scientific Officer at Siegfried, joined the Swiss-based CDMO in January 2025 after 16 years at Evonik, where he led innovation management for healthcare, ran drug substance operations in the US, and headed sales across Asia.
Read more.